Volume 11 Issue 6
Jan.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(6): 685-691
Sun Shu, Liu Zhijia, Li Xiang, et al. Preliminary study of cytomegalovirus infection and its correlation with NK cell subsets after renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(6): 685-691. doi: 10.3969/j.issn.1674-7445.2020.06.006
Citation: Sun Shu, Liu Zhijia, Li Xiang, et al. Preliminary study of cytomegalovirus infection and its correlation with NK cell subsets after renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(6): 685-691. doi: 10.3969/j.issn.1674-7445.2020.06.006
shu

Preliminary study of cytomegalovirus infection and its correlation with NK cell subsets after renal transplantation

doi: 10.3969/j.issn.1674-7445.2020.06.006

  • Organ Transplantation Institute of 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China

More Information
  • Corresponding author: Shi Bingyi, Email: shibingyi666@126.com
  • Received Date: 2020-07-30
    Available Online: 2021-01-19
  • Publish Date: 2021-01-19
    Abstract
  •   Objective  To explore the variation trend of natural killer (NK) cell subsets in the recipients infected with cytomegalovirus (CMV) after renal transplantation.  Methods  Clinical data of 92 renal transplant recipients were retrospectively analyzed. All recipients were divided into the CMV infection group (n=43), CMV infection recovery group (n=13), stable renal function group (n=15), rejection group (n=11) and other infection group (n=10). In addition, healthy adult volunteers were enrolled in the healthy control group (n=15). The proportion of NK cells in peripheral blood, the expression proportion and the mean fluorescence intensity (MFI) of CD226 and CD16 in NK cells were observed and statistically compared among different groups.  Results  The proportion of NK cells was 4.9% (2.2%, 11.5%) in the CMV infection group and 3.7% (2.3%, 6.5%) in the CMV infection recovery group, which were significantly lower than those in the other groups (all P < 0.05). The expression proportion of CD226 and CD16 in NK cells in the CMV infection group was significantly lower compared with those in the healthy control group and stable renal function group(all P < 0.05). The expression proportion of CD226 and CD16 in NK cells in the CMV infection recovery group was remarkably higher than those in the CMV infection group (both P < 0.05). The MFI of CD226 and CD16 in the CMV infection group was significantly lower than those in the healthy control group (both P < 0.05). The MFI of CD226 and CD16 in the CMV infection recovery group was significantly higher than those in the CMV infection group (both P < 0.05).  Conclusions  The expression proportion and MFI of CD226 and CD16 in NK cells are down-regulated in CMV infection period, whereas up-regulated during the CMV infection recovery period, prompting that CD226 and CD16 expressed by NK cells are intimately correlated with the course of CMV infection.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    王祥慧.2013肾脏移植国际前沿热点及新进展——What's Hot? What's New?[J/CD].实用器官移植电子杂志, 2013, 1(4): 203-204.

    WANG XH. International frontier hot spots and new progress on renal transplantation in 2013: What's Hot? What's New?[J/CD]. Pract J Organ Transplant (Electr Vers), 2013, 1(4): 203-204.
    [2]
    范宇, 石炳毅, 钱叶勇, 等.肾移植术后BK病毒感染对移植肾功能影响的临床研究[J].器官移植, 2018, 9(1):51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.

    FAN Y, SHI BY, QIAN YY, et al. Clinical study on the effect of BK virus infection on renal allograft function after renal transplantation[J]. Organ Transplant, 2018, 9(1):51-57. DOI: 10.3969/j.issn.1674-7445.2018.01.007.
    [3]
    NETO MM, COSTA RS, FREZZA G, et al. Cytomegalovirus-associated glomerulonephritis in a kidney transplant recipient[J]. Prog Transplant, 2018, 28(4):398-399. DOI: 10.1177/1526924818800034.
    [4]
    LEE H, PARK KH, RYU JH, et al. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients[J]. PLoS One, 2017, 12(12):e0189488. DOI: 10.1371/journal.pone.0189488.
    [5]
    乔良伟, 曲青山, 苗书斋.肾移植术后巨细胞病毒肺炎患者发生急性呼吸窘迫综合征的危险因素探讨[J].中华医院感染学杂志, 2013, 23(13):3146-3148. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201313043

    QIAO LW, QU QS, MIAO SZ. Risk factors of cytomegalovirus pneumonia in patients with acute respiratory distress syndrome after renal transplantation[J]. Chin J Nosocom, 2013, 23(13):3146-3148. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201313043
    [6]
    REUSING JO JR, FEITOSA EB, AGENA F, et al. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: outcome and risk factors for late CMV disease[J]. Transpl Infect Dis, 2018, 20(5):e12929. DOI: 10.1111/tid.12929.
    [7]
    KIM SH, LEE HJ, KIM SM, et al. Diagnostic usefulness of cytomegalovirus (CMV)-specific T cell immunity in predicting CMV infection after kidney transplantation: a pilot proof-of-concept study[J]. Infect Chemother, 2015, 47(2):105-110. DOI: 10.3947/ic.2015.47.2.105.
    [8]
    金春明.肾移植后巨细胞病毒感染的检测[J].中国组织工程研究, 2012, 16(40):7572-7579. DOI: 10.3969/j.issn.2095-4344.2012.40.029.

    JIN CM. Detection of cytomegalovirus infection after renal transplantation[J]. Chin J Tissue Eng Res, 2012, 16(40):7572-7579. DOI: 10.3969/j.issn.2095-4344.2012. 40.029.
    [9]
    LENAC ROVIS T, KUCAN BRLIC P, KAYNAN N, et al. Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection[J]. J Exp Med, 2016, 213(9):1835-1850. DOI: 10.1084/jem.20151899.
    [10]
    NABEKURA T, KANAYA M, SHIBUYA A, et al. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection[J]. Immunity, 2014, 40(2):225-234. DOI: 10.1016/j.immuni.2013.12.011.
    [11]
    KOTTON CN, KUMAR D, CALIENDO AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J]. Transplantation, 2018, 102(6):900-931. DOI: 10.1097/TP.0000000000002191.
    [12]
    杨春媚, 张婷婷, 钱程, 等. NK细胞抗肿瘤机制及相关免疫疗法的研究进展[J].中国药理学通报, 2019, 35(11):1492-1496. DOI: 10.3969/j.issn.1001-1978.2019. 11.003.

    YANG CM, ZHANG TT, QIAN C, et al. Progress in research on anti-tumor mechanism of NK cell and its related immunotherapy[J]. Chin Pharmacol Bull, 2019, 35(11):1492-1496. DOI: 10.3969/j.issn.1001-1978. 2019.11.003.
    [13]
    BARRY KC, HSU J, BROZ ML, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments[J]. Nat Med, 2018, 24(8):1178-1191. DOI: 10.1038/s41591-018-0085-8.
    [14]
    刘志佳, 于涛, 孙曙, 等.巨细胞病毒感染下调肾移植受者NK细胞CD226和CD16的表达[J].细胞与分子免疫学杂志, 2015, 31(10):1391-1395. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201510022

    LIU ZJ, YU T, SUN S, et al. Cytomegalovirus infection down-regulates the expressions of CD226 and CD16 in blood NK cells of the renal transplant recipient[J]. Chin J Cell Mol Immunol, 2015, 31(10):1391-1395. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201510022
    [15]
    DRICK N, SEELIGER B, GREER M, et al. DNA-based testing in lung transplant recipients with suspected non-viral lower respiratory tract infection: a prospective observational study[J]. Transpl Infect Dis, 2018, 20(1): e12811. DOI: 10.1111/tid.12811.
    [16]
    SARMIENTO E, CIFRIAN J, CALAHORRA L, et al. Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: a multicenter prospective study[J]. J Heart Lung Transplant, 2018, 37(8):1001-1012. DOI: 10.1016/j.healun. 2018.04.001.
    [17]
    KHVEDELIDZE M, CHKHARTISHVILI N, ABASHIDZE L, et al. Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study[J]. Georgian Med News, 2008(165):78-83. http://europepmc.org/abstract/MED/19124922
    [18]
    JIANG Y, CUI X, CUI C, et al. The function of CD3+CD56+ NKT-like cells in HIV-infected individuals[J]. Biomed Res Int, 2014:863625. DOI: 10.1155/2014/863625.
    [19]
    TAURIAINEN J, SCHARF L, FREDERIKSEN J, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals[J]. Sci Rep, 2017, 7:40354. DOI: 10.1038/srep40354.
    [20]
    MATUSALI G, POTESTÀ M, SANTONI A, et al. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR[J]. J Virol, 2012, 86(8):4496-4504. DOI: 10.1128/JVI.05788-11.
    [21]
    LOZANO E, DOMINGUEZ-VILLAR M, KUCHROO V, et al. The TIGIT/CD226 axis regulates human T cell function[J]. J Immunol, 2012, 188(8):3869-3875. DOI: 10.4049/jimmunol.1103627.
    [22]
    BRUEL T, GUIVEL-BENHASSINE F, AMRAOUI S, et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies[J]. Nat Commun, 2016, 7:10844. DOI: 10.1038/ncomms10844.
    [23]
    MIKULAK J, ORIOLO F, ZAGHI E, et al. Natural killer cells in HIV-1 infection and therapy[J].AIDS, 2017, 31(17):2317-2330. DOI: 10.1097/QAD. 0000000000001645.
    [24]
    BERNARD NF, KIANI Z, TREMBLAY-MCLEAN A, et al. Natural killer (NK) cell education differentially influences HIV antibody-dependent NK cell activation and antibody-dependent cellular cytotoxicity[J]. Front Immunol, 2017, 8:1033. DOI: 10.3389/fimmu. 2017.01033.
    [25]
    FLÓREZ-ÁLVAREZ L, HERNANDEZ JC, ZAPATA W. NK Cells in HIV-1 infection: from basic science to vaccine strategies[J]. Front Immunol, 2018, 9:2290. DOI: 10.3389/fimmu.2018.02290.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (408) PDF downloads(40) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return